The Impact of Some Modulators of the Renin-Angiotensin System on the Scopolamine-Induced Memory Loss Mice Model

被引:0
|
作者
Ababei, Daniela-Carmen [1 ,2 ]
Balmus, Ioana-Miruna [3 ]
Bild, Walther [4 ,5 ]
Ciobica, Alin Stelian [4 ,6 ,7 ]
Lefter, Radu Marian [4 ]
Rusu, Razvan-Nicolae [1 ]
Stanciu, Gabriela Dumitrita [2 ]
Cojocaru, Sabina [6 ]
Hancianu, Monica [8 ]
Bild, Veronica [1 ,2 ,4 ]
机构
[1] Grigore T Popa Univ Med & Pharm, Pharmacodynam & Clin Pharm Dept, 16 Univ St, Iasi 700115, Romania
[2] Grigore T Popa Univ Med & Pharm, Ctr Adv Res & Dev Expt Med CEMEX, 16 Univ St, Iasi 700115, Romania
[3] Alexandru Ioan Cuza Univ, Inst Interdisciplinary Res, Dept Exact Sci & Nat Sci, Iasi 700506, Romania
[4] Romanian Acad, Ctr Biomed Res, B Carol I 8, Iasi 700505, Romania
[5] Grigore T Popa Univ Med & Pharm, Dept Physiol, 16 Univ St, Iasi 700115, Romania
[6] Alexandru Ioan Cuza Univ, Fac Biol, Dept Biol, Iasi 700506, Romania
[7] Acad Romanian Scientists, Splaiul Independentei 54 ,Sect 5, Bucharest 050094, Romania
[8] Univ Med & Pharm Grigore T Popa Iasi, Fac Pharm, Dept Pharmacognosy, 16 Univ St, Iasi 700115, Romania
关键词
RAAS; cognitive functions; oxidative stress; Ramipril; Losartan; scopolamine; blood serum; brain; mice model; antioxidant effect; CONVERTING ENZYME-INHIBITORS; REDUCES OXIDATIVE STRESS; II RECEPTOR BLOCKERS; LOSARTAN; BLOCKADE; RAMIPRIL; ANXIETY; INFLAMMATION; IMPAIRMENT; DOXEPIN;
D O I
10.3390/brainsci13081211
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
As some of the renin-angiotensin-aldosterone system (RAAS)-dependent mechanisms underlying the cognitive performance modulation could include oxidative balance alterations, in this study we aimed to describe some of the potential interactions between RAAS modulators (Losartan and Ramipril) and oxidative stress in a typical model of memory impairment. In this study, 48 white male Swiss mice were divided into six groups and received RAAS modulators (oral administration Ramipril 4 mg/kg, Losartan 20 mg/kg) and a muscarinic receptors inhibitor (intraperitoneal injection scopolamine, 0.5 mg/kg) for 8 consecutive days. Then, 24 h after the last administration, the animals were euthanized and whole blood and brain tissues were collected. Biological samples were then processed, and biochemical analysis was carried out to assess superoxide dismutase and glutathione activities and malondialdehyde concentrations. In the present experimental conditions, we showed that RAAS modulation via the angiotensin-converting enzyme inhibition (Ramipril) and via the angiotensin II receptor blockage (Losartan) chronic treatments could lead to oxidative stress modulation in a non-selective muscarinic receptors blocker (scopolamine) animal model. Our results showed that Losartan could exhibit a significant systemic antioxidant potential partly preventing the negative oxidative effects of scopolamine and a brain antioxidant potential, mainly by inhibiting the oxidative-stress-mediated cellular damage and apoptosis. Ramipril could also minimize the oxidative-mediated damage to the lipid components of brain tissue resulting from scopolamine administration. Both blood serum and brain changes in oxidative stress status were observed following 8-day treatments with Ramipril, Losartan, scopolamine, and combinations. While the serum oxidative stress modulation observed in this study could suggest the potential effect of RAAS modulation and scopolamine administration on the circulatory system, blood vessels endothelia, and arterial tension modulation, the observed brain tissues oxidative stress modulation could lead to important information on the complex interaction between renin-angiotensin and cholinergic systems.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] RENIN INHIBITORS - SPECIFIC MODULATORS OF THE RENIN-ANGIOTENSIN SYSTEM
    LUTHER, RR
    STEIN, HH
    GLASSMAN, HN
    KLEINERT, HD
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1989, 39-1 (01): : 1 - 5
  • [2] EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE ON ANXIETY AND MEMORY IN MICE
    Ababei, Daniela Carmen
    Lefter, Radu
    Ciobica, Alin
    Antioh, Iulia
    Barbu, Roxana Mihaela
    Arcan, Oana Dana
    Beschea Chiriac, Sorin Ioan
    Zbarcea, Cristina
    Bild, Walther
    Bild, Veronica
    FARMACIA, 2017, 65 (03) : 381 - 389
  • [3] Sulforaphane alleviates scopolamine-induced memory impairment in mice
    Lee, Siyoung
    Kim, Jisung
    Seo, Sang Gwon
    Choi, Bo-Ryoung
    Han, Jung-Soo
    Lee, Ki Won
    Kim, Jiyoung
    PHARMACOLOGICAL RESEARCH, 2014, 85 : 23 - 32
  • [4] Gomisin A improves scopolamine-induced memory impairment in mice
    Kim, Dong Hyun
    Hung, Tran Manh
    Bae, Ki Hwan
    Jung, Ji Wook
    Lee, Seungjoo
    Yoon, Byung Hoon
    Cheong, Jae Hoon
    Ko, Kwang Ho
    Ryu, Jong Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 542 (1-3) : 129 - 135
  • [5] A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice
    Ababei, Daniela Carmen
    Bild, Veronica
    Ciobica, Alin
    Lefter, Radu Marian
    Rusu, Razvan Nicolae
    Bild, Walther
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2019, 34 (05): : 329 - 336
  • [6] RENIN-ANGIOTENSIN SYSTEM IN GENETICALLY HYPERTENSIVE MICE
    IWAO, H
    NAKAMURA, N
    KIM, S
    IKEMOTO, F
    YAMAMOTO, K
    SCHLAGER, G
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1984, 48 (11): : 1270 - 1279
  • [7] RENIN-ANGIOTENSIN SYSTEM IN GENETICALLY HYPERTENSIVE MICE
    IWAO, H
    NAKAMURA, N
    KIM, S
    IKEMOTO, F
    YAMAMOTO, K
    SCHLAGER, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P195 - P195
  • [8] How to explain the differences between renin-angiotensin system modulators
    Levy, BI
    JOURNAL OF HYPERTENSION, 2005, 23 : S401 - S402
  • [9] Preventing the cardiovascular disease continuum with renin-angiotensin system modulators
    Hall, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S422 - S422
  • [10] Evaluation of the renin-angiotensin system in individual mice
    Nussberger, J
    Nicoud, F
    Wiesel, P
    Brunner, DB
    Pedrazzini, T
    HYPERTENSION, 1997, 30 (03) : P60 - P60